I, L., M, B., AL, N., H, F., A, M., SWK, N., . . . K, E. (2018). Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia. Blood cancer journal, 8(6), 52. https://doi.org/10.1038/s41408-018-0087-2
Chicago Style (17th ed.) CitationI, Laverdière, Boileau M, Neumann AL, Frison H, Mitchell A, Ng SWK, Wang JCY, Minden MD, and Eppert K. "Leukemic Stem Cell Signatures Identify Novel Therapeutics Targeting Acute Myeloid Leukemia." Blood Cancer Journal 8, no. 6 (2018): 52. https://doi.org/10.1038/s41408-018-0087-2.
MLA (9th ed.) CitationI, Laverdière, et al. "Leukemic Stem Cell Signatures Identify Novel Therapeutics Targeting Acute Myeloid Leukemia." Blood Cancer Journal, vol. 8, no. 6, 2018, p. 52, https://doi.org/10.1038/s41408-018-0087-2.